GLI1 reduces drug sensitivity by regulating cell cycle through PI3K/AKT/GSK3/CDK pathway in acute myeloid leukemia
Cheng Zhou(Hunan Normal University), Hui Zeng(First Affiliated Hospital of Jinan University)
Cited by 47
Related Papers
A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells
|Molecular Medicine|2023|8
Targeting HMGCS1 restores chemotherapy sensitivity in acute myeloid leukemia
|Blood Science|2024|4
GANT61 surmounts drug resistance of ADR by upregulating lysosome activities and reducing BCL2 expression in HL-60/ADR cells
|Cancer Cell International|2024|0